Recent Articles from TheStreet

Here's Why Google's Pixel Could Sap Apple and Samsung's Supremacy

Google Switches From Qualcomm Chip to Its Own on New Smartphones

The phones will contain “Google Tensor, the brand new chip designed by Google, custom-made for Pixel,” the company tweeted.

Midday Report: Dow Struggles After Days of Records; Square Halves Quarterly Net Loss

Stock Market Today With Jim Cramer: August Trading and Square

Jim Cramer warns of the August swoon and says that he believes Square's purchase of Afterpay is 'an overpay.'

General Motors Lead

General Motors Earnings Preview: Here Are the Must-Know Levels

General Motors will report earnings later this week. Here are the must-know levels now for the stock.

Square Lead

Square Stock Is Sitting on the Cusp of a Major Breakout

Square stock is rallying hard after reports of its $29 billion all-stock deal to acquire Afterpay. Let's look at the charts for a potential breakout.

Under Armour Has a Lot to Prove With the Upcoming Curry 4 Basketball Sneaker

Under Armour Stock Rises After Baird's Positive Trading Call

Under Armour has 'a favorable operating environment that has supported accelerated two-year growth,' says Baird analyst Jonathan Komp.

Square Lead

5 Top Stock Gainers for Monday: Square, Levi Strauss, Vaxart

Square, ON Semiconductor, Levi Strauss, Vaxart and ImmunoGen are five top stock gainers for Monday.

39. Reese Witherspoon

Reese Witherspoon's Hello Sunshine to Be Sold to Blackstone-Backed Firm

Hello Sunshine, the media business founded by Reese Witherspoon, announces it agreed to be bought by a company backed by Blackstone.

ON Semiconductor Rises After Needham Hikes Price Target

ON Semiconductor Stock Rises on Earnings Beat and Strong Guidance

ON Semiconductor see 'accelerating demand' for its products in its strategic automotive and industrial end-markets.

XPO Logistics: Cramer's Top Takeaways

XPO Logistics Stock Rises After Spinoff of GXO Logistics

XPO Logistics rises after the company finalizes its spinoff of GXO Logistics.

Exicure Genetics Lead

Exicure Stock Soars on Ipsen Huntington’s Disease Treatment Deal

Exicure will receive $20 million upfront and be eligible to receive as much as $1 billion in option exercise fees and milestone payments.